The Company
The People


The Principals

The founders of siRNAx, Inc have varied academic backgrounds that together position them ideally to accomplish this mission.

Michael R. Simon, M.D., President

Michael R. Simon received his M.D. from New York University School of Medicine. He is Clinical Professor Emeritus in the Departments of Internal Medicine and Pediatrics, Wayne State University School of Medicine, Detroit, MI. Dr. Simon is a clinical immunologist who is the co-founder of siRNAx , Inc. He is the co-inventor of the relevant intellectual property.

R. Michael Garavito, Ph.D., Chief Scientific Officer

R. Michael Garavito, Ph.D. is Professor of Biochemistry at Michigan State University.  He received his Ph.D. from Purdue University, then did postdoctoral research at the Biozentrum of the University of Basel, Switzerland.  His research has made important contributions to the methodology of protein expression, purification, crystallization, and structure determination, particularly of membrane proteins. He has extensive experience in the understanding of the structure, function, and biosynthesis of proteins.  His most recent research efforts have been focused on the design and expression of novel protein structures that are designed for unique functions.  This has enabled the engineering of novel antibody-based delivery vehicles for siRNA. Dr. Garavito is the co-inventor of the relevant intellectual property.

Chief Executive Officer

R. Scott Olson, MBA, is siRNAx’s CEO. Following a career in finance, Mr. Olson began consulting to life science companies in 1999. He earned an MBA from the Ross School of Business at the University of Michigan. He has founded or been an executive in seven companies, including Unitech Pharmaceuticals, a therapeutic company acquired by GeneBlue Corporation. He has consulted hundreds of emerging companies in strategic and financial matters.